Evidence map›Paper›PMID 32079317›Full record

ArticleJournal of clinical medicine2020

Measuring Vitamin D Status in Chronic Inflammatory Disorders: How does Chronic Inflammation Affect the Reliability of Vitamin D Metabolites in Patients with IBD?

Aysegül Aksan, Dilem Tugal, Nathalena Hein, Katharina Boettger, Yurani Caicedo-Zea, Ina Diehl, Claudia Schumann, Franz-Paul Armbruster, Jürgen Stein

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Aysegül AksanInterdisciplinary Crohn Colitis Center Rhein-Main, Schifferstr. 59, 60594 Frankfurt am Main, Germany.
Dilem TugalInterdisciplinary Crohn Colitis Center Rhein-Main, Schifferstr. 59, 60594 Frankfurt am Main, Germany.
Nathalena HeinDGD Clinics Sachsenhausen, 60594 Frankfurt am Main, Germany.
Katharina BoettgerInterdisciplinary Crohn Colitis Center Rhein-Main, Schifferstr. 59, 60594 Frankfurt am Main, Germany.
Yurani Caicedo-ZeaImmundiagnostik AG, 64625 Bensheim, Germany.
Ina DiehlImmundiagnostik AG, 64625 Bensheim, Germany.
Claudia SchumannImmundiagnostik AG, 64625 Bensheim, Germany.
Franz-Paul ArmbrusterImmundiagnostik AG, 64625 Bensheim, Germany.
Jürgen SteinInterdisciplinary Crohn Colitis Center Rhein-Main, Schifferstr. 59, 60594 Frankfurt am Main, Germany.
Immundiagnostik (Germany) · DEGoethe University Frankfurt · DEKrankenhaus Sachsenhausen · DEHacettepe University · TR

Funding

Immundiagnostik AG N/A
6 · The paper itself

Abstract

Evidence gained from recent studies has generated increasing interest in the role of vitamin D in extraskeletal functions such as inflammation and immunoregulation. Although vitamin D deficiency has been implicated in the pathophysiology of inflammatory diseases including inflammatory bowel disease (IBD), evidence as to whether vitamin D supplementation may cure or prevent chronic disease is inconsistent. Since 25OH-vitamin D (25OHD) has been suggested to be an acute-phase protein, its utility as a vitamin D status marker is therefore questionable. In this study, possible interactions of vitamin D and inflammation were studied in 188 patients with IBD, with high-sensitivity C-reactive protein (hsCRP) levels ≥ 5 mg/dL and/or fecal calprotectin ≥ 250 µg/g defined as biochemical evidence of inflammatory activity. Levels of 25OHD and vitamin D-binding protein (VDBP) were determined by ELISA, and 1,25-dihydroxyvitamin D (1,25OHD) and dihydroxycholecalciferol (24,25OHD) by LC-MS/MS. Free and bioavailable vitamin D levels were calculated with the validated formula of Bikle. Serum 1,25OH2D and vitamin D binding protein (VDBP) levels were shown to differ between the inflammatory and noninflammatory groups: patients with inflammatory disease activity had significantly higher serum concentrations of 1,25OH2D (35.0 (16.4-67.3) vs. 18.5 (1.2-51.0) pg/mL,

Indexed as

biomarkerchronic inflammationinflammatory bowel diseaseVitamin Dvitamin D deficiencyvitamin D metabolites

Identifiers

PMID32079317
PMCPMC7074478
OpenAlexW3006277857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.